A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.
Authors
Clemons, MarkMarshall, E
Dürig, J
Watanabe, K
Howell, Anthony
Miles, D
Earl, H
Kiernan, Julie
Griffiths, Audrey
Towlson, K
DeTakats, P
Testa, Nydia G
Dougal, Mark
Hunter, M G
Wood, L M
Czaplewski, L G
Millar, A
Dexter, T Michael
Lord, Brian I
Affiliation
CRC Department of Medical Oncology and Paterson Institute for Cancer Research, Christie Hospital, Manchester; ICRF Clinical Oncology Unit, Guy's Hospital, London.Issue Date
1998-09-01